Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Oxaliplatin in Advanced Colorectal Cancer
NCT00004187Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jun 1999
- Primary completion
- Apr 2004
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in colorectal cancer (CRC), sponsored by Swiss Group for Clinical Cancer Research. Started Jun 1999; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00004187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004187.